Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;63(6):709-19.
doi: 10.1002/ana.21388.

Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia

Affiliations

Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia

Marsel Mesulam et al. Ann Neurol. 2008 Jun.

Abstract

Objective: To identify predictors of Alzheimer's disease (AD) versus frontotemporal lobar degeneration pathology in primary progressive aphasia (PPA), and determine whether the AD pathology is atypically distributed to fit the aphasic phenotype.

Methods: Neuropsychological and neuropathological analyses of 23 consecutive PPA autopsies. All had qualitative determination of neurofibrillary tangle (NFT) density. Additional quantitation was done in four of the PPA/AD cases and four AD cases with the typical amnestic dementia of the Alzheimer type.

Results: The sample contained mostly logopenic, agrammatic, and mixed forms of PPA. All six agrammatics had frontotemporal lobar degeneration (five of six with tauopathy). Seven of the 11 logopenics had AD. In logopenics, lower memory scores increased the probability of AD, but there were exceptions. The PPA/AD group showed predominance of entorhinal NFT typical of the amnestic dementia of the Alzheimer type. In the small subgroup examined quantitatively, neocortical NFTs were more numerous in the left hemisphere of PPA/AD. However, the asymmetry was low and inconsistent. Neuritic plaques did not display consistent asymmetry. Apolipoprotein E4, a major risk factor for typical AD, did not predict AD pathology in PPA.

Interpretation: Subtyping PPA helps to predict AD versus frontotemporal lobar degeneration pathology at the group level. However, our results and the literature also indicate that no clinical predictor is completely reliable in individual patients. The inconsistent concordance of NFT distribution with the asymmetric atrophy and the nonamnestic phenotype also raises the possibility that the AD markers encountered at autopsy in PPA may not always reflect the nature of the initiating neurodegenerative process.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Coronal magnetic resonance imaging (MRI) scan of Case 8 done 1 year after onset. The left perisylvian cistern is wider (asterisk), indicating more atrophy on that side. Postmortem examination also showed asymmetry, with greater microvacuolation in the left neocortex. However, there were no asymmetries of neurofibrillary tangle (NFT) distribution. Visual inspection of the MRI also showed that perisylvian atrophy was more severe than medial temporal atrophy. However, the NFT density did not show a perisylvian over entorhinal predominance. This patient illustrates the inconsistency of correlation between atrophy patterns and NFT distribution in primary progressive aphasia/Alzheimer’s disease (PPA/AD).

References

    1. Braak H, Braak E. Evolution of the neuropathology of Alzheimer’s disease. Acta Neurol Scand. 1996;165 suppl:3–12. - PubMed
    1. Guilloz AL, Weintraub S, Mash DC, Mesulam M-M, et al. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol. 2003;60:729–736. - PubMed
    1. Bobinski M, Wegiel J, Wisniewski HM, et al. Neurofibrillary pathology—correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol Aging. 1996;17:909–919. - PubMed
    1. Jack CR, Slomkowski M, Gracon S, et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology. 2003;60:253–260. - PMC - PubMed
    1. McKhann G, Drachman DA, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease. Neurology. 1984;34:939–944. - PubMed

Publication types

MeSH terms